In vitro myocardial effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956).
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D004558:Electric Stimulation; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D008738:Methyl Ethers / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D011941:Receptors, Adrenergic / Q000187:drug effects; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D001593:Benzyl Compounds; D007093:Imidazoles; D007659:Ketones; D008738:Methyl Ethers; D011941:Receptors, Adrenergic; D007545:Isoproterenol; D002118:Calcium